BSX Income Statement
Boston Scientific Corp - Revenue, Expenses & Profit Analysis
Stock Price
$76.85
Market Cap
$112.40B
P/E Ratio
39.0
EPS (TTM)
$1.94
Most Recent Quarter
Period: 2024-12-31(2024-12-31)
Revenue
Total sales from operations
$16.75B
+17.6% YoY
Net Income
Bottom line profit
$1.85B
Margin: 0.1%
Earnings Per Share (Diluted)
Net income per share
$1.25
Profitability Metrics
Gross Margin
68.8%
Operating Margin
0.2%
Net Margin
0.1%
Return on Equity
0.1%
Historical Income Statements
| Period | Revenue | Gross Profit | Operating Income | Net Income | EPS |
|---|---|---|---|---|---|
| 2024-12-31 | $16.75B | - | - | $1.85B | $1.25 |
| 2023-12-31 | $14.24B | - | - | $1.59B | $1.07 |
| 2022-12-31 | $12.68B | - | - | $698.00M | $0.45 |
| 2021-12-31 | $11.89B | - | - | $1.04B | $0.69 |
| 2020-12-31 | $9.91B | - | - | $-82.00M | $-0.08 |
View Complete Financial Analysis
Full income statements, balance sheets, cash flows, and AI-powered insights
Open Full AnalysisFrequently Asked Questions
What is BSX's revenue?
BSX's most recent quarterly revenue was $16.75B, representing a growth of 17.6% year-over-year.
Is BSX profitable?
BSX reported a profit of $1.85B in the most recent quarter. The net profit margin is 0.1%.
What is BSX's operating income?
Operating income data is available in the income statement.
What is BSX's earnings per share (EPS)?
BSX reported diluted earnings per share of $1.25 in the most recent quarter.
What is BSX's gross profit margin?
BSX has a gross profit margin of 68.8%, indicating the profitability of core operations before operating expenses.